Patent · US Active

Benzhydryl derivatives

US9145409B2 · kind B2 · utility

1Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2014
Grant dateSep 29, 2015
Priority date—
Expiry dateDec 4, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having a benzhydryl structure represented by formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for treating diseases of the respiratory tract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.